
    
      Patients with primary neoplastic brain tumors (Grades II-IV) will participate in this trial.
      Each patient will have been evaluated and found to have such a tumor by history and recent
      imaging studies (MRI) and deemed a surgical candidate based on current neurosurgical
      standards of care.
    
  